Digestive System Carcinoma: Clinical Trials

7 trials for Digestive System Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 3 Not applicable, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Active not recruiting 1
Phase 12Terminated 1, Withdrawn 1
Phase 21Completed 1

Follow Digestive System Carcinoma: new trials by email Literature Review of Digestive System Carcinoma trials Research Report on Digestive System Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Target-specific immunoPET Imaging of Digestive System Carcinoma
[68Ga]Ga-DOTA-H2D3, [18F]F-RESCA-RB14, [68Ga]Ga-NOTA-T4 - Malignancy, Digestive Cancer
Not applicableRecruitingRenJi Hospital4002024-12-042025-12-31
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Acupuncture Therapy, Acupressure Therapy, Oral Cryotherapy - Appendix Carcinoma, Colon Carcinoma
Phase 2CompletedUniversity of Washington782021-06-012026-01-21
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
Best Practice, Functional Assessment, Medical Device Usage and Evaluation - Digestive System Carcinoma, Genitourinary System Carcinoma
Not applicableActive not recruitingCity of Hope Medical Center3982021-02-162026-08-20
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
Lorcaserin, Lorcaserin Hydrochloride, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Phase 1WithdrawnOhio State University Comprehensive Cancer Center2020-11-012021-01-19
Cancer Genetic Testing in Ethnic Populations
Biospecimen Collection, Genetic Testing - Breast Carcinoma, Carcinoma of Unknown Primary
Not applicableRecruitingMayo Clinic18002020-01-132026-04-02
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
Monitoring Device, Quality-of-Life Assessment - Digestive System Carcinoma, Head and Neck Carcinoma
CompletedMontefiore Medical Center412015-06-012026-04-13
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
Bevacizumab, Cetuximab, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Castleman Disease
Phase 1TerminatedM.D. Anderson Cancer Center1162012-10-162026-11-05

Narrower conditions

Appendiceal Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Colonic Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Gastrointestinal Neoplasms (2)  ·  Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Rectal Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Adenoma, Islet Cell (1)  ·  Anus Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Transitional Cell (1)

Broader conditions

Neoplasms by Site (5)  ·  Endocrine System Diseases (3)  ·  Head and Neck Neoplasms (3)  ·  Neoplasms (3)  ·  Breast Diseases (2)  ·  Carcinoma (2)  ·  Cecal Diseases (2)  ·  Cecal Neoplasms (2)  ·  Colonic Diseases (2)  ·  Colorectal Neoplasms (2)  ·  Digestive System Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)

Interventions

Acupressure (1)  ·  Acupuncture Therapy (1)  ·  Bevacizumab (1)  ·  Cetuximab (1)  ·  Cryotherapy (1)  ·  Disulfides (1)  ·  Genetic Testing (1)  ·  Immunoglobulin G (1)  ·  Monitoring, Physiologic (1)  ·  Nutrition Assessment (1)  ·  Practice Guidelines as Topic (1)  ·  Sirolimus (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)  ·  Valproic Acid (1)

Sponsors

City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Montefiore Medical Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  RenJi Hospital (1)  ·  University of Washington (1)

Countries

United States (5)  ·  China (1)

Top investigators

Jewel Samadder, M.D. (1)  ·  Maryam B Lustberg, MD (1)  ·  Nitin Ohri (1)  ·  Sarina A Piha-Paul (1)  ·  Stacey Cohen (1)  ·  Virginia Sun (1)  ·  Weijun Wei (1)

Results publications

PMID 26933802, PMID 37311055, PMID 40877442, PMID 41389341

NIH funding

P30CA013330 (1), P30CA015704 (1), P30CA016058 (1), P30CA033572 (1)